Robert P. Blau, M.D.

Dr. Blau has been providing medical and surgical management for Vitreo-retinal problems since 1973. He completed his Residency at Sinai Hospital of Detroit and a fellowship in Vitreo-retinal Surgery at the University of Wisconsin in Madison, WI. He has been in private practice in the Detroit area since that time and is on the teaching faculty of The Detroit Medical Center and Sinai-Grace Hospital. He has contributed to the understanding of diseases of the retina and vitreous through multiple clinical presentations and publications.

He has special interests in Diabetic Retinopathy, Macular Disorders, Retinal Detachments, and Retinal Vascular Disorders. He was one of the first Doctors in Michigan to utilize Ophthalmic Ultrasound, Retinal Fluorescent Photography, Laser Photocoagulation and Vitreous Surgery in the diagnosis and treatment of Vitreo-Retinal Diseases.

He is certified by the American Board of Ophthalmology and is a member of The Vitreous Society, The American Society for Lasers in Medicine and Surgery, The International Society for Ophthalmic Ultrasound, Michigan Ophthalmological Society, and several others.

Dr. Blau has privileges at the following hospitals:

• William Beaumont Hospital, Royal Oak, MI
  
• St. Joseph Mercy Hospital Oakland, Pontiac, MI
  
• St. John - Macomb Hospital, Warren, MI
  
• Detroit Medical Center, Detroit, MI
  
• Crittenton Hospital, Rochester, MI

[top]

Marshall N. Cyrlin, M.D.

Marshall N. Cyrlin, M.D. did his Residency in Ophthalmology at the University of Illinois, Eye and Ear Infirmary and did a Clinical and Research Fellowship in Glaucoma at Harvard University, Massachusetts Eye and Ear Infirmary. Dr. Cyrlin is board certified by the American Board of Ophthalmology and is a charter member of the American Glaucoma Society specialty group. He is Director of the Glaucoma Service at Beaumont Eye Institute, Royal Oak, Michigan. Dr. Cyrlin has an appointment as Clinical Professor of Biomedical Sciences (Ophthalmology), Eye Research Institute, Oakland University and has been actively involved in clinical trials of glaucoma pharmaceutical agents. He has published several book chapters and numerous papers dealing with glaucoma diagnostics and therapeutics and has lectured nationally and internationally. Dr. Cyrlin has received an Honor Award from the American Academy of Ophthalmology and has been listed in Best Doctor’s in America.

Education

• M.D. degree, Washington University, School of Medicine, St. Louis, Missouri
• B.A. degree, Northwestern University, Weinberg College of Arts and Sciences , Evanston, Illinois Postgraduate Training
• Fellowship in Glaucoma , Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts
• Residency in Ophthalmology, University of Illinois, Eye and Ear Infirmary Chicago, Illinois
• Medical Internship, Washington University, Jewish Hospital St. Louis, Missouri

Postgraduate Training

• Fellowship in Glaucoma , Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts
• Residency in Ophthalmology, University of Illinois, Eye and Ear Infirmary Chicago, Illinois
• Medical Internship, Washington University, Jewish Hospital St. Louis, Missouri

Honors and Awards

• Beta Beta Beta (Biology Honorary), Northwestern University
• Marcy Scholar, Northwestern University
• B.A. awarded with "Highest Distinction" (Summa Cum Laude), Northwestern University
• Phi Beta Kappa
• American Academy of Ophthalmology, Honor Award
• Citation in Best Doctors in America

Board Certifications

• Diplomate National Board of Medical Examiners
• Diplomate American Board of Ophthalmology

Professional Societies

• Fellow, American Academy of Ophthalmology
• Member, American Glaucoma Society
• Member, American Society of Cataract and Refractive Surgery
• Member, Association for Research in Vision and Ophthalmology
• Member, International Perimetric Society
• Member, Society of Heed Fellows
• Member, American Academy of Ophthalmic Executives
• Member, Michigan Ophthalmological Society

Current Positions

• Glaucomatologist, Associated Vision Consultants, Southfield, Pontiac, Warren, Michigan
• Director, Glaucoma Service, Beaumont Eye Institute, Royal Oak, Michigan
• Member, Resident Education Committee, William Beaumont Hospital, Royal Oak, Michigan
• Clinical Professor of Biomedical Sciences (Ophthalmology), Eye Research Institute, Oakland University, Rochester, Michigan
• Member, Editorial Board, Glaucoma Management News, Slack Publications
• Member, Alumni Admissions Council, Northwestern University, Evanston, Illinois
• Attending Ophthalmologist
  St. John, Macomb Hospital Center, Warren, Michigan
  St. Joseph Hospital Pontiac, Michigan
  Huron Valley Hospital, Detroit Medical Center, Commerce Township, Michigan

Previous Positions

• Assistant Clinical Professor of Ophthalmology, Michigan State University, East Lansing, MI
• Assistant Professor of Ophthalmology, Chief, Glaucoma Division, Department of Ophthalmology University of Florida College of Medicine, Gainesville, Florida
• Assistant Professor of Ophthalmology, Chief Resident, Ophthalmology University of Illinois, Eye and Ear Infirmary, Chicago, Illinois
• Instructor, Ophthalmology, Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts

Recent Research Grants

• Principal Investigator, Protocol C-05-13, Patient Dosing with TRAVATAN using the TRAVATAN Dosing Aid, Alcon Laboratories, Ft. Worth, Texas
• Principal Investigator, Protocol CAT-152- 0202, A multicenter randomized, open-label study to compare subconjunctival injections of 100µg human anti-TGFß2 monoclonal antibody with an intraoperative sponge application of 5-fluorouracil following first time trabeculectomy., Cambridge Antibody Technology, London, England
• Principal Investigator, Director, Advanced Glaucoma Intervention Study, National Eye Institute, Oakland University Center, Michigan
• Principal Investigator, Protocol 124-00/COS510, A Parallel, Randomized, Observer Masked, Multicenter Study Comparing the Ocular Hypotensive Effect of 2% Dorzolamide Hydrochloride/0.5% Timolol Maleate Combination Ophthalmic Solution to the Concomitant Administration of 0.2% Brimonidine Tartrate Ophthalmic Solution and Timolol Maleate Ophthalmic Solution in Patients with Elevated Intraocular Pressure, Merck & Co., Inc., Whitehouse Station, New Jersey
• Co-Investigator, Associate Director, Glaucoma Laser Trial, National Eye Institute, Detroit, Michigan

Recent Presentations

• Correlation of Visual Function with Optic Nerve Structure in Glaucoma Suspects. Cyrlin MN, Rosenshein JS: 2nd International Glaucoma Symposium, Jerusalem, Israel, March, 1998.
• Glaucoma Clinical Case Presentations. Cyrlin MN: Optometric Grand Rounds ’98, Troy, Michigan, May, 1998.
• Contact Diode Laser Cyclocoagulation: A Comparison of Shorter-Duration, Higher-Power vs. Longer-Duration, Lower-Power Treatment in Uncontrolled Glaucoma. Cyrlin MN, Tressler CT, Rosensheim JS, Corbin PS: Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, Florida, May, 1998.
• Advances in Glaucoma Diagnostics. Cyrlin MN: Spectrum ’98 Troy, Michigan, October, 1998
• Short-Wavelength-Automated Perimetry, Frequency Doubling Perimetry, and Pattern-Erg Detect Early Glaucomatous Optic Neuropathy. Presentor: Bayer, A. , Discussant: Cyrlin, MN: American Academy of Ophthalmology, New Orleans, Louisiana, November 1998.
• Glaucoma Pharmacology Update. Cyrlin MN: Ophthalmology Grand Rounds, William Beaumont Hospital, Royal Oak, Michigan, January, 1999.
• Perspectives in the Medical Management of Glaucoma. Cyrlin MN: East West Eye Meeting, Cleveland, Ohio November 2002
• A Patients Guide to Cataract and Glaucoma. Cyrlin, MN: Guest Speaker, Rotary Organization, Troy, Michigan November 2003
• Central Corneal Thickness (CCT) in the Management of Glaucoma. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico February 2004
• The Pharmacologic Management of Wound Healing in Trabeculectomy. Surgery. Cyrlin, MN Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico February 2004
• Role of Anti-Fibrosis Agents in Trabeculectomy Surgery. Cyrlin, MN: Ocular Surgery News Symposium, Glaucoma: Improving Your Odds, Las Vegas, Nevada, June 2004
• Alpha Adrenergic Agents in Glaucoma Management. Cyrlin, MN: Ocular Surgery News Symposium, Glaucoma: Improving Your Odds, Las Vegas, Nevada, June 2004
• Compliance and Adherence in the Management of Glaucoma- When Just Writing a Prescription is not Enough. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2005
• Determination of Target Intraocular pressure in Glaucoma Patients- Why and How to Set Goals. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2005
• Current Concepts in Glaucoma Management. Cyrlin, MN: Contemporary Eye Meeting, Pittsburgh, Pennsylvania, April 2005
• Laser Trabeculoplasty. Cyrlin, MN: Contemporary Eye Meeting, Pittsburgh, Pennsylvania, April 2005

Recent Publications

• Cyrlin MN: Automated Perimetry. The Glaucomas. Ritch, R., Shields, M.B., Krupin, T., eds. CV MosbyCo., St. Louis, MO, 2nd Edition 1996; 539-615.
• Rosenshein JS, Cyrlin MN, Fazio R.: Does Cardiac Synchronization Improve Heidelberg Retina Tomograph (HRT) Imaging of the Optic Nerve, Invest OphthalmolVis Sci 1996; 37:3, S1091.
• Tressler, C.T., Cyrlin, M.N., Rosenshein, J.S. and Fazio, R.: Subconjunctival Versus Intrascleral Mitomycin-C in Trabeculectomy. Ophth. Surgery and Lasers, 1996; 27:8 661-666.
• Cyrlin, M.N.: Intraocular Pressure Rise Following Laser Surgery. Chandler and Grant’s Glaucoma.. Epstein, D.L., eds, Allingham, R.R., Shuman, J.S. Williams and Wilkins, Baltimore, MD, 1997;
  470 - 471.
• Cyrlin MN, Tressler CS, Rosensheim JS, Corbin PS: Contact Diode Laser Cyclocoagulation: A Comparison of Shorter-Duration, Higher-Power vs. Longer-Duration, Lower-Power Treatment in Uncontrolled Glaucoma, Invest Ophthalmol Vis Sci, 1998; 39:4, S471.
• The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 3. Baseline Characteristics of Black and White Patients, Ophthalmology 1998; 105. 1137 1145.
• The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of Treatment Outcomes within Race, Ophthalmology 1998, 105,1146-1164.
• The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS) 5. Encapsulated Bleb After Initial Trabeculectomy. American Journal of Ophthalmology, 127:8-19, 1999. (Writing Committee: Schwartz, AL, Van Veldhuisen, PC, Gaasterland, DE, Ederer, F, Sullivan, EK, Cyrlin, MN)
• Cyrlin MN: Malignant Glaucoma. Principles and Practice of Ophthalmology: Clinical Practice 2nd ed. Albert, D.M., Jakobiec, F.A., eds. W. B. Saunders Co., Philadelphia, PA, 1999; 2634-2646.
• The AGIS Investigators:Advanced Glaucoma Intervention Study (AGIS): 7. The Relationship Between Control of Intraocular Pressure and Visual Field Deterioration. American Journal of Ophthalmology, 130:4-429, 2000. (Writing Committee: Van Veldhuisen, PC, Ederer, F Gaasterland, DE, Sullivan, EK, Beck A, Prum BE, Cyrlin, MN, Weiss, H)
• The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 6. Effect of cataract on visual field and visual acuity. Arch. Ophthalmol. In press, November 2000.
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy. Archives of Ophthalmology 2001; 119:1771-1780.
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. American Journal of Ophthalmology 2001;132:311-320.
• Gaasterland DE, Blackwell B, Dally LG, Caprioli, J, Katz LJ, Ederer F, and the AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 10. Variability among academic glaucoma subspecialists in assessing optic disc notching. Transactions of the American Ophthalmological Society 2001;99:177-185.
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. American Journal of Ophthalmology 2002;134:481-498.
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. American Journal of Ophthalmology 2002:134:499-512
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race. Ten-year results. Ophthalmology 2004;111:651-664.
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations. Ophthalmology 2004;111:2109-2116.
• Cyrlin MN: Target Intraocular Pressure: Protect but do no harm, Glaucoma Management News, 2005; 3:3, 4-5,9.

Dr Cyrlin has privileges at the following hospitals:

• William Beaumont Hospital, Royal Oak, MI
  
• St. Joseph Mercy Hospital Oakland, Pontiac, MI
  
• St. John - Macomb Hospital, Warren, MI
  
• Huron Valley Hospital, Detroit Medical Center, Detroit, MI

[top]

Asher Weiner, M.D.

Dr. Asher Weiner joined Associated Vision Consultants in 2001 from his former positions as Director of Ophthalmology and Director of University Ophthalmic Consultants at Long Island College Hospital, Brooklyn, New York. He is a Clinical Associate Professor in Biomedical Sciences (Ophthalmology) at the Research Eye Institute, Oakland University, as well as Assistant Professor of Ophthalmology at State University of New York (SUNY Downstate). In addition to his residency in Ophthalmology, Dr. Weiner completed a Clinical Fellowship in Glaucoma at The Wills Eye Hospital in Philadelphia, and he previously completed a Clinical Fellowship at The Harvard University Massachussetts Eye and Ear Infirmary in Ocular Electrophysiology. Dr. Weiner is board certified by the American Board of Ophthalmology, a Fellow of the American Academy of Ophthalmology, and a Member of the American Glaucoma Society.

Education

• B.Sc.- Hebrew University and Hadassah Medical School, Jerusalem, Israel
  
• M.D.- Hebrew University and Hadassah Medical School, Jerusalem, Israel
• Residency in Ophthalmology, St. Luke's Medical Center, Cleveland, OH
  
• Clinical Glaucoma Fellowship; Wills Eye Hospital, Philadelphia, PA.
  
• Clinical Fellowship in Ophthalmology, Harvard Medical School, The Berman-Gund Laboratory for the Study of Retinal Degenerations, and the Electroretinography Service, The Massachusetts Eye & Ear Infirmary, Boston, Massachusetts
  
• Residency in Ophthalmology, Hebrew University Medical School and Hadassah University Hospital, Jerusalem, Israel
  
• Transitional (Internship) Year, Henry Ford Hospital, Detroit, Michigan
  
• Internship in Medicine, Hadassah University Hospital, Jerusalem, Israel

Honors and Awards

• The Henry Weiller's scholarship, Israel
  
• Scholarship, American Physicians Fellowship, Inc.
  
• Honorary mention; "Foveal ERG in diabetic macular edema" research, St. Luke's Medical Center, Cleveland, Ohio.
  
• First prize; "Foveal outer retinal dysfunction: an independent cause of central visual loss in normal-tension glaucoma," St. Luke's Medical Center, Cleveland, Ohio.
  
• Honorary mention; "Occult foveal cone dysfunction: a frequent cause of central visual loss or Symptoms" research project contest, St. Luke's Medical Center, Cleveland, Ohio.

Board Certifications

• Diplomate, American Board of Ophthalmology
  
• Diplomate, Israel Board of Ophthalmology
  
• Diplomate, Israel Medical Board

Professional Societies

• Fellow, American Academy of Ophthalmology
• Member, American Glaucoma Society
• Member, Association for Research in Vision and Ophthalmology (ARVO)
• Member, International Society of Spaeth Glaucoma Fellows
• Member, Michigan Ophthalmological Society
• Member, Israel Society for Eye & Vision Research

Current Positions

• Clinical Associate Professor of Biomedical Sciences (Ophthalmology), Eye Research Institute, Oakland University, Rochester, MI
• Glaucoma Consultant and Surgeon, Associated Vision Consultants, Southfield, Pontiac, Warren, MI
• Member, Resident Education Committee, William Beaumont Hospital, Royal Oak, MI
• Glaucoma Teaching Staff, William Beaumont Hospital, Royal Oak, MI
• Attending Ophthalmologist and Glaucoma Surgeon at:
  • William Beaumont Hospital, Royal Oak, MI
  • St. John, Macomb Hospital, Warren, MI
  • St. Joseph Hospital, Pontiac, MI
  • Huron Valley Hospital, Detroit Medical Center, Commerce Township, MI

Previous Positions

• Director, Ophthalmology Services, Long Island College Hospital, Brooklyn, New York
  
• Director, University Ophthalmic Consultants, Long Island College Hospital, Brooklyn, New York
  
• Assistant Professor of Ophthalmology, State University of New York (SUNY Downstate), (current position).
  
• Director, ERG Diagnostic Services, and Research Coordinator, Division of Ophthalmology, St. Luke's Medical Center, Cleveland, Ohio.
  
• Ophthalmologist on Staff; Director, ERG and Retinal Degenerations Service; Hadassah University Hospital, Jerusalem, Israel.
  
• Clinical Instructor in Ophthalmology, Hebrew University and Hadassah Medical School, Jerusalem, Israel.

Recent Presentations

• American Academy of Ophthalmology (AAO) annual meeting, San Francisco, CA: Foveal outer retinal dysfunction: an independent cause of central visual loss in normal-tension glaucoma.
  
• 2nd International Glaucoma Symposium, Jerusalem, Israel: Foveal outer retinal function and central visual field loss in normal-tension glaucoma.
  
• Association for Research in Vision and Ophthalmology (ARVO) annual meeting, Fort Lauderdale, FL: Further studies of foveal outer retinal function in normal-pressure glaucoma (NPG) and primary open-angle glaucoma (POAG).
  
• Cleveland Ophthalmological Society: Foveal cone Dysfunction syndrome; Diagnosis by foveal ERG.
  
• Cleveland Ophthalmological Society: Child of parents with Usher's Syndrome.
  
• Cleveland Ophthalmological Society: Occult foveal cone dysfunction; A frequent cause of unexplained central visual loss or symptoms.
  
• Cleveland Ophthalmological Society: Lightning retinopathy.
  
• Wills Eye Hospital Research Conference, Philadelphia, PA: Heidelberg Retinal Tomography vs. the Spaeth glaucoma staging system in the diagnosis of glaucoma.

Recent Publications

• Weiner A, Christopoulos VA, Gussler CH, Kaufman SR, Adams DH, Kohn HD, Weidenthal DT. Abnormal change in foveal cone ERG with increasing duration of light exposure in diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37(Suppl):342.
  
• Christopoulos VA, Weiner A, Gussler CH, Kaufman SR, Adams DH, Weidenthal DT, Kohn HD. Foveal cone ERG in diabetic macular edema. Invest Ophthalmol Vis Sci. 1996;37(Suppl):342.
  
• Gussler CH, Singha P, Weiner A, Lewin J. Pediatric MRI lacrimal gland dimensions. Invest Ophthalmol Vis Sci 1997;38:S127.
• Schmidt ME, Weiner A, Patel S, Gussler CH, Weidenthal DT, Kohn HD. Foveal cone ERG in unexplained central visual loss. Invest Ophthalmol Vis Sci 1997;38:S879.
  
• Weiner A, Ripkin DJ, Patel S, Schmidt ME, Kohn HD, Weidenthal DT. Foveal cone function in normal-tension glaucoma. Invest Ophthalmol Vis Sci 1997;38:S573.
  
• Weiner A, Christopoulos VA, Gussler CH, Adams DH, Kaufman SR, Kohn HD, Weidenthal DT. Foveal cone function in non-proliferative diabetic retinopathy and macular edema. Invest Ophthalmol Vis Sci 1997;38:1443-9.
  
• Weiner A, Halpert M, El-Fakieh AM. Potential Acuity Meter testing in suspected factitious non-asymmetric central visual loss. Ann Ophthalmol and Glaucoma 1998;30:81-85.
  
• Sandberg MA, Weiner A, Miller S, Gaudio AR. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 1998;105:441-447.
  
• Weiner A, Ripkin DJ, Adler RT, Kohn HD, Weidenthal DT. Further studies of foveal outer retinal function in normal-pressure glaucoma (NPG) and primary open-angle glaucoma (POAG). Invest Ophthalmol Vis Sci 1998;39:S896.
  
• Weiner A, Schmidt ME, Patel S, Gussler CH, Remler, BF, Kaufman SR, Kohn HD, Weidenthal DT. Foveal outer retinal function in eyes with unexplained visual symptoms or acuity loss. Arch Ophthalmol 1998;116:1161-1168.
  
• Weiner A, Ripkin DJ, Patel S, Kaufman SR, Kohn HD, Weidenthal DT. Foveal dysfunction and central visual field loss in glaucoma. Arch Ophthalmol 1998;116:1169-1174.
  
• Weiner A, Patel S, Kohn HD, Weidenthal DT. Full-field and foveal electroretinography (ERG) data in an unusual form of lightning-associated retinopathy. Invest Ophthalmol Vis Sci 1999;40:S955.
  
• Weiner A, Pereira M.L.M., Smith A.F., Spaeth G.L. Heidelberg Retinal Tomography vs. Spaeth glaucoma staging system and clinical impression in the diagnosis of glaucoma. Invest Ophthalmol Vis Sci 2000;41:S519.
  
• F. Zizi, C. Magai, G. Jean-Louis, H. von Gizycki, A. Wolintz, A. Weiner, K. Greenidge. Prevalence of Sleep Complaints in Visually Impaired Elderly: Contribution of Ethnic Differences. Invest Ophthalmol Vis Sci 2001;42:S863.
• A. Weiner, R. Ruffy, S.R. Sarkisian, O. Konykhov, D. Simon, F. Zizi, Silicone-assisted Guarded Filtration Procedure (SGFP). Invest Ophthalmol Vis Sci 2002; 43: ARVO Abstract 3354.

[top]

Go to Top | Home | News | Contact Us | About AVC | The Doctors | Services | Locations | Map
Patient Education- Glaucoma & Cataract | Patient Education- Retina & Vitreous